http://medicalxpress.com/ en-us Medical Xpress internet news portal provides the latest news on Health and Medicine. (Medical Xpress)—Scientists studying the brain scans of chronic fatigue patients have found they use additional brain regions to do simple tasks requiring attention. This may explain the problems many sufferers have with memory. The findings are just one of several new studies being presented today [22 Apr] at the launch of a new UK-wide research body to advance understanding and treatment into this debilitating condition which affects over 600,000 people in the UK. http://medicalxpress.com/news/2013-04-patients-chronic-fatigue-additional-areas.html Diseases, Conditions, Syndromes Tue, 23 Apr 2013 09:35:32 EST news285928525 A research study of more than 600 black patients with uncontrolled hypertension found that less than half were prescribed a diuretic drug with proven benefit that costs just pennies a day, report researchers at Weill Cornell Medical College and the Visiting Nurse Service of New York's (VNSNY) Center for Home Care Policy and Research. The researchers say these new findings should be taken as a serious wake-up call for physicians who treat black patients with hypertension. http://medicalxpress.com/news/2013-01-black-patients-hypertension-diuretics.html Cardiology Tue, 22 Jan 2013 16:59:27 EST news278096353 Psychological science has come of age. But the rights of a mature discipline carry with them responsibilities, among them the responsibility to maximize confidence in our findings through good data practices and replication. http://medicalxpress.com/news/2012-11-replication-psychological-science.html Psychology & Psychiatry Thu, 08 Nov 2012 16:56:31 EST news271616128 A workshop sponsored by NIH's National Institute of Neurological Disorders and Stroke (NINDS) has produced a set of consensus recommendations to improve the design and reporting of animal studies. By making animal studies easier to replicate and interpret, the workshop recommendations are expected to help funnel promising therapies to patients. http://medicalxpress.com/news/2012-10-workshop-animal.html Other Wed, 10 Oct 2012 15:21:06 EST news269101225 (Medical Xpress) -- This week the Journal of the American Medical Association published a study with unfortuate news for the millions of people who suffer from multiple sclerosis. In the large study, a therapy known as interferon beta failed to stave off the progression of the incurable disease. Albert Lo, associate professor of neurology and epidemiology, comments on what the study means for patients, why it was well-designed, and how a new effort to support research on the disease in Rhode Island could help. http://medicalxpress.com/news/2012-07-multiple-sclerosis-drug-disappoints-disability.html Neuroscience Mon, 23 Jul 2012 07:41:11 EST news262248063 For the first time, a new research methodology recently approved by the Food and Drug Administration has been used to demonstrate that converting patients from one anti-epileptic drug to another - in this case, lamotrigine extended-release (LTG XR) - is well-tolerated, effective and safe. The work by Jacqueline French and her team, from New York University in the US, illustrates how the new methodology addresses ethical issues inherent in more traditional study designs. It is published online in Springer's journal, Neurotherapeutics. http://medicalxpress.com/news/2011-12-ethical-epilepsy-treatments.html Neuroscience Mon, 05 Dec 2011 13:19:48 EST news242313386